Getinge AB (GETI B):企業の財務・戦略的SWOT分析

◆英語タイトル:Getinge AB (GETI B) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14017
◆発行会社(調査会社):GlobalData
◆発行日:2019年2月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Getinge AB (GETI B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Getinge AB (Getinge) is a medical technology company that designs, develops and markets equipment and instruments in the areas of surgery, infection control, intensive care, care ergonomics and wound care. Its major products include surgical tables, lights, ventilators and anesthesia equipment, heart-lung machines with accompanying disposables, equipment and instruments for cardiac surgery, vascular surgery; cardiac assist devices; patient lifting devices, hospital beds, stretchers and couches, mattresses for treating and preventing pressure sores, disinfectors, sterilization equipment, and documentation systems and accessories. The company has manufacturing facilities in various parts of the world and sells its products through proprietary sales companies and network of distributors. Getinge is headquartered in Vastra Gotaland, Sweden.

Getinge AB Key Recent Developments

Feb 07,2019: Datascope, a subsidiary of Getinge, receives a warning letter from the US Food and Drug Administration (FDA) at the Mahwah site in the US
Jan 30,2019: Getinge publishes Year-end report for January-December 2018
Jan 14,2019: Getinge innovations make it easier to secure sterility in drug manufacturing
Dec 10,2018: Johan Malmquist proposed as new Chairman of the Board for Getinge
Nov 26,2018: Getinge Informs About a Voluntary Medical Device Recall for the QUADROX-i Neonatal Oxygenator

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Getinge AB – Key Facts
Getinge AB – Key Employees
Getinge AB – Key Employee Biographies
Getinge AB – Major Products and Services
Getinge AB – History
Getinge AB – Company Statement
Getinge AB – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Getinge AB – Business Description
Business Segment: Acute Care Therapies
Overview
Performance
Business Segment: Life Science
Performance
Business Segment: Surgical Workflows
Overview
Performance
Geographical Segment: Americas
Target Markets
Performance
Geographical Segment: APAC
Target Markets
Performance
Geographical Segment: EMEA
Target Markets
Performance
R&D Overview
Getinge AB – Corporate Strategy
Getinge AB – SWOT Analysis
SWOT Analysis – Overview
Getinge AB – Strengths
Getinge AB – Weaknesses
Getinge AB – Opportunities
Getinge AB – Threats
Getinge AB – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Getinge AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
Getinge AB, Medical Equipment, Deals By Type, 2013 to YTD 2019
Getinge AB, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 07, 2019: Datascope, a subsidiary of Getinge, receives a warning letter from the US Food and Drug Administration (FDA) at the Mahwah site in the US
Jan 30, 2019: Getinge publishes Year-end report for January-December 2018
Jan 14, 2019: Getinge innovations make it easier to secure sterility in drug manufacturing
Dec 10, 2018: Johan Malmquist proposed as new Chairman of the Board for Getinge
Nov 26, 2018: Getinge Informs About a Voluntary Medical Device Recall for the QUADROX-i Neonatal Oxygenator
Nov 12, 2018: Getinge names Stephane Le Roy as president business area surgical workflows and member of Getinge executive team
Nov 01, 2018: Getinge clarifies FDA communication to health care providers
Oct 18, 2018: Getinge publishes interim report for January-September 2018
Oct 14, 2018: Getinge makes $200m provision for Atrium Medical surgical mesh claims
Oct 02, 2018: Getinge USA Sales provides Maquet Moduevo Ceiling Supply Unit 10-year warranty
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Getinge AB, Key Facts
Getinge AB, Key Employees
Getinge AB, Key Employee Biographies
Getinge AB, Major Products and Services
Getinge AB, History
Getinge AB, Other Locations
Getinge AB, Subsidiaries
Getinge AB, Key Competitors
Getinge AB, Ratios based on current share price
Getinge AB, Annual Ratios
Getinge AB, Annual Ratios (Cont...1)
Getinge AB, Annual Ratios (Cont...2)
Getinge AB, Interim Ratios
Getinge AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
Getinge AB, Medical Equipment, Deals By Type, 2013 to YTD 2019
Getinge AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Getinge AB, Performance Chart (2014 - 2018)
Getinge AB, Ratio Charts
Getinge AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
Getinge AB, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Getinge AB (GETI B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Guangshen Railway Company Limited:企業の戦略・SWOT・財務情報
    Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report Summary Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Nexstar Media Group, Inc. (NXST):企業の財務・戦略的SWOT分析
    Nexstar Media Group, Inc. (NXST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Benesse Holdings, Inc. (9783):企業の財務・戦略的SWOT分析
    Benesse Holdings, Inc. (9783) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Exalenz Bioscience Ltd (EXEN):医療機器:M&Aディール及び事業提携情報
    Summary Exalenz Bioscience Ltd (Exalenz) carries out the development and commercialization of advanced medical systems for a range of gastrointestinal (GI) tract and liver disorders. The company harnesses its BreathID technology platform for assessment and monitoring of functional diseases. Its flag …
  • Siemens Gamesa Renewable Energy SA (SGRE):電力:M&Aディール及び事業提携情報
    Summary Siemens Gamesa Renewable Energy SA (SGRE), formerly Gamesa Corporacion Tecnologica, S.A., is a supplier of wind power solutions. The company designs, manufactures and sells wind turbines. The product portfolio of the company includes offshore and onshore products. It also provides industry-l …
  • Kane Biotech Inc (KNE)-医療機器分野:企業M&A・提携分析
    Summary Kane Biotech Inc (Kane Biotech) is a developer of pharmaceutical products that prevent and remove microbial biofilms. The company uses patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms. It develop …
  • Huntsman Corp (HUN):企業の財務・戦略的SWOT分析
    Huntsman Corp (HUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Piramal Enterprises Ltd (PEL):企業の財務・戦略的SWOT分析
    Piramal Enterprises Ltd (PEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Michael Hill International Limited (MHJ):企業の財務・戦略的SWOT分析
    Michael Hill International Limited (MHJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Cardax Inc (CDXI):製薬・医療:M&Aディール及び事業提携情報
    Summary Cardax Inc (Cardax), formerly Cardax Pharmaceuticals Inc is a life science company that discovers and develops pharmaceutical and consumer health technologies. The company discovers and develops anti-inflammatory dietary supplements, small molecule therapies, medicinal products, and drug pro …
  • ZIOPHARM Oncology Inc (ZIOP):製薬・医療:M&Aディール及び事業提携情報
    Summary Ziopharm Oncology Inc (Ziopharm), formerly EasyWeb Inc, is a next-generation immune therapies provider. The company offers controlled IL-12 and t-cell therapy. Its next-generation immune therapie platform provides turning cold tumors hot by activating an immune response and non viral genetic …
  • HomeWorks Tri-County Electric Cooperative Inc:企業の発電所・SWOT分析2018
    HomeWorks Tri-County Electric Cooperative Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, in …
  • Doosan Fuel Cell America Inc:電力:M&Aディール及び事業提携情報
    Summary Doosan Fuel Cell America Inc (Doosan Fuel Cell), formerly Quantum Leap Technology Inc, a subsidiary of Doosan Corp, is a energy solution provider that manufactures and markets clean energy solutions. The company provides installation, remote monitoring and control, equipment service, financi …
  • Suzlon Energy Ltd (SUZLON):企業の財務・戦略的SWOT分析
    Suzlon Energy Ltd (SUZLON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Lund University:製薬・医療:M&Aディール及び事業提携情報
    Summary Lund University (LNU) is an educational service provider that offers master and bachelor programmes. It offers education and research in the areas of engineering, economics and management, science, law, social sciences, medicine, humanities, theology, fine art, music and others. The universi …
  • Ra Pharmaceuticals Inc (RARX):医療機器:M&Aディール及び事業提携情報
    Summary Ra Pharmaceuticals Inc (Ra Pharmaceuticals) is a clinical stage biopharmaceutical company that develops therapeutics for the treatment of diseases caused due to uncontrolled activation of the complement system. Ra Pharmaceuticals develops its pipeline products through its proprietary peptide …
  • bluebird bio Inc (BLUE):企業の財務・戦略的SWOT分析
    bluebird bio Inc (BLUE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • 3E sanv:企業の戦略的SWOT分析
    3E sanv - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • XTEK Limited:企業の戦略・SWOT・財務分析
    XTEK Limited - Strategy, SWOT and Corporate Finance Report Summary XTEK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Evelo Biosciences Inc (EVLO):製薬・医療:M&Aディール及び事業提携情報
    Summary Evelo Biosciences Inc (Evelo Biosciences), formerly Evelo Therapeutics Inc is a clinical stage biotechnology company. It focuses on the development of novel medicines designed to act on immune cells in the gut-body network for the treatment of inflammatory diseases and cancer. The company's …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆